KKR

Manipal, EQT in Lead for INR 6,838 Cr Sahyadri Deal June 30, 2025 Manipal Hospitals and EQT are leading the race to acquire Sahyadri Hospitals from OTPP. Other bidders include AsterDM and IHH, while KKR has exited but recently extended a $600 million credit to Manipal Group.

KKR-Backed IVI Signs $450 Mn Deal to Acquire ART Fertility Clinics June 10, 2025 KKR-backed IVI RMA Global, a US-based leader in infertility treatment, is set to acquire ART Fertility clinics for $400-450 million.

KKR, TPG in Early-Stage Buyout Talks for Relisys Medical Devices June 3, 2025 Global investment firms KKR and TPG are reportedly in preliminary discussions to acquire Hyderabad-based med-tech manufacturer Relisys Medical Devices.

KKR Commits $600 Mn in Debt Funding to Manipal Group for Growth Expansion June 3, 2025 Global investment firm KKR has announced a $600 million debt investment into the Manipal Group, one of India's most prominent healthcare and education conglomerates.

Bidding War Intensifies for Sahyadri Hospitals, Acquisition Valued at INR 5,500 Cr May 14, 2025 The acquisition of Sahyadri Hospitals has reached a key stage, with four major bidders advancing. The potential INR 5,500 Cr deal reflects growing strategic interest in India’s expanding healthcare sector.

KKR Nears Deal to Buy Japanese Medical Gear Maker Topcon: Reports April 1, 2025 US investment firm KKR is reportedly close to acquiring Tokyo-based medical equipment manufacturer Topcon Corporation. Sources indicate that discussions are ongoing, and the transaction size has yet to be finalized.

KKR Sells 5.8% Stake in JB Chemicals & Pharmaceuticals for INR 1,460 Cr March 28, 2025 Global investment firm KKR has divested a 5.8% stake in JB Chemicals and Pharmaceuticals, raising INR 1,460 Cr through open market transactions. According to bulk deal data from the National Stock Exchange (NSE), KKR’s Tau Investment Holdings Pte, the promoter entity of JB Chemicals, offloaded 89.83 lakh shares in four separate transactions.

KKR to Acquire 54% Stake in Cancer Care Chain HCG for $400 Mn February 24, 2025 Private equity firm KKR to acquire a 54% stake in cancer care hospital chain HCG for $400 million, expanding oncology infrastructure in India.

KKR to Acquire 51% Stake in HCG from CVC Capital Partners February 14, 2025 Global investment firm KKR is set to acquire Healthcare Global Enterprises (HCG), a leading cancer care provider in India, strengthening its foothold in the country’s healthcare sector.

Uniting for Better Care: A Deep Dive into 2024’s Biggest Hospital M&As December 31, 2024 Explore the major mergers and acquisitions in the healthcare sector of 2024. Stay informed on key transactions, industry shifts, and their potential impact on the market.

KKR Set to Acquire HCG in Deal with CVC Capital December 5, 2024 KKR is in advanced talks to acquire Healthcare Global Enterprises Ltd (HCG), the largest specialty cancer care hospital chain in India, from CVC Capital Partners. The acquisition could lead to a delisting of HCG, with KKR set to drive expansion in non-metro areas.

KKR & GIC to Exit $3.2 Bn Stake in Metro Pacific Health September 26, 2024 KKR and GIC have appointed banks to oversee the sale of their 80% stake in Metro Pacific Health, the Philippines' largest private healthcare group. The deal could value the company at $3.2 billion.